SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹16,491 Cr | ₹15,086 Cr | ₹12,749 Cr | ₹11,588 Cr | ₹9,882 Cr |
What is the latest Operating Profit of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹16,491 Cr |
| Mar2025 | ₹15,086 Cr |
| Mar2024 | ₹12,749 Cr |
| Mar2023 | ₹11,588 Cr |
| Mar2022 | ₹9,882 Cr |
How is Operating Profit of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹16,491 Cr | 9.31 | |
| Mar2025 | ₹15,086 Cr | 18.33 | |
| Mar2024 | ₹12,749 Cr | 10.02 | |
| Mar2023 | ₹11,588 Cr | 17.26 | |
| Mar2022 | ₹9,882 Cr | - | |
Compare Operating Profit of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,778.6 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| MANKIND PHARMA | ₹106,460.0 Cr | 1.2% | 6.6% | -5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
6.8% |
16.3% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses